Wasatch BioLabs and Oxford Nanopore Team Up to Accelerate Methylation Sequencing Towards Clinical Use
- Whole genome
- Methylation
- Metagenomics
- cfDNA
- High-throughput
November 1 2024
Oxford Nanopore Technologies selected by Murdoch Children’s Research Institute to support landmark research into faster genetic screening for rare dis
- Whole genome
- Long-read
- Clinical research
- Clinical
- DNA
August 9 2024
Oxford Nanopore and Kaust collaborate to advance multi-omic discovery
- Whole genome
- DNA
- Environment
- High-throughput
- Identification
- Long-read
September 25 2024
Oxford Nanopore’s ORG.one hits milestone, announces new focus on endangered species
- Whole genome
- Long-read
May 8 2024
Oxford Nanopore announces landmark UK Government partnership to advance genomics-driven healthcare innovation in the UK | Oxford Nanopore Technologies
- Whole genome
- Bioinformatics
- Data storage
- Epigenetics
- Cancer research
- Human genomics
November 5 2024
Oxford Nanopore, Action for ME, and University of Edinburgh launch groundbreaking study into the genetics of ME
- Whole genome
- DNA
- Long-read
December 16 2024
Interview: Tumoroids from colon cancer, including WGS-strategy
- Whole genome
- Cancer research
July 26 2022
Interview: Old is new: maximizing read lengths and yield for genome assembly
- Whole genome
- RNA
- cDNA
- Interview
October 22 2019
Blog: Resolving structural variants causing antithrombin deficiency
- Whole genome
- Human genomics
- Clinical research
- Structural variation
- Variant calling
- Long-read
September 14 2020
Blog: cuteSV - a powerful tool to uncover the full spectrum of genomic structural variants
- Whole genome
- Structural variation
- PromethION
- DNA
- gDNA
- Long-read
October 19 2020
Al Jalila Children’s Hospital advances rare disease identification through Oxford Nanopore sequencing, a new study shows | Oxford Nanopore Technologies
- Whole genome
- Clinical research
- Long-read
- PromethION
November 14 2024